Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update
Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company
PlantSpring: Our Innovation Engine
PlantSpring™ builds on our experience engineering plant metabolism and our proprietary systems to unleash the natural capabilities of the plant, the original biological system. By leveraging predictive and analytics tools, we drive down production cycle times and harness plant chemistries in a robust and sustainable manner.
BioFactory: Our Production System
Driven by our PlantSpring™ Technology platform, Calyxt’s bioreactor-based production system, the BioFactory™, enables the controlled replication and processing of plant-based molecules producing compounds using a matrix of plant cells. Using Calyxt’s BioFactory customers can manufacture complex, scarce plant compounds year-round indoors, protected from any adverse climate effects.
Growing a More Sustainable World, One Innovation at a Time
At Calyxt, we believe in the power and possibilities of plants. Discover how our PlantSpring platform and BioFactory can enable you to achieve your sustainability goals.
Leveraging Calyxt’s Expertise and Legacy
Calyxt’s Technology Licensing opportunity spans our vast intellectual property library built over ten years as a leading biotechnology company, including multiple gene editing platforms, plant breeding, and other capabilities.